CN1049455A - 改善生物利用度的新型口服药剂 - Google Patents

改善生物利用度的新型口服药剂 Download PDF

Info

Publication number
CN1049455A
CN1049455A CN90106874A CN90106874A CN1049455A CN 1049455 A CN1049455 A CN 1049455A CN 90106874 A CN90106874 A CN 90106874A CN 90106874 A CN90106874 A CN 90106874A CN 1049455 A CN1049455 A CN 1049455A
Authority
CN
China
Prior art keywords
oxodipine
prosobel
calcium ion
bioavailability
ion inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN90106874A
Other languages
English (en)
Chinese (zh)
Inventor
丹尼斯·贝藏松
让-马克·艾阿什
阿伦·迪富尔
法布里斯·埃格罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Delagrange SA
Original Assignee
Laboratoires Delagrange SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Delagrange SA filed Critical Laboratoires Delagrange SA
Publication of CN1049455A publication Critical patent/CN1049455A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN90106874A 1989-08-07 1990-08-06 改善生物利用度的新型口服药剂 Pending CN1049455A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8910605A FR2650502B1 (fr) 1989-08-07 1989-08-07 Nouvelle forme galenique orale ameliorant la biodisponibilite
FR8910605 1989-08-07

Publications (1)

Publication Number Publication Date
CN1049455A true CN1049455A (zh) 1991-02-27

Family

ID=9384532

Family Applications (1)

Application Number Title Priority Date Filing Date
CN90106874A Pending CN1049455A (zh) 1989-08-07 1990-08-06 改善生物利用度的新型口服药剂

Country Status (25)

Country Link
EP (1) EP0412877A1 (enExample)
JP (1) JPH0377819A (enExample)
KR (1) KR910004181A (enExample)
CN (1) CN1049455A (enExample)
AU (1) AU631235B2 (enExample)
CA (1) CA2022447A1 (enExample)
CS (1) CS383890A3 (enExample)
DD (1) DD297332A5 (enExample)
DE (1) DE4023136A1 (enExample)
FI (1) FI903885A7 (enExample)
FR (1) FR2650502B1 (enExample)
GB (1) GB2234898A (enExample)
HU (1) HU204997B (enExample)
IE (1) IE902629A1 (enExample)
IL (1) IL95105A0 (enExample)
IN (1) IN170789B (enExample)
LU (1) LU87777A1 (enExample)
MA (1) MA21923A1 (enExample)
NO (1) NO903442L (enExample)
NZ (1) NZ234593A (enExample)
OA (1) OA09301A (enExample)
PE (1) PE491A1 (enExample)
PT (1) PT94823A (enExample)
TN (1) TNSN90111A1 (enExample)
ZA (1) ZA905886B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2133633T3 (es) * 1992-01-17 1999-09-16 Alfatec Pharma Gmbh Procedimiento para la produccion de polvos, granulados o peletes que contienen una sustancia activa, con una estructura a base de macromoleculas hidrofilas, y su utilizacion.
DE4221880A1 (de) * 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen
KR20030089147A (ko) * 2002-05-16 2003-11-21 슈라펫 주식회사 애완동물용 급수통

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE854414C (de) * 1949-04-26 1952-11-04 Dieter Dr Med Ellenbeck Verfahren zur Herstellung von injizierbaren Loesungen von an sich mehr oder weniger schwer loeslichen Arzneimitteln
GB715874A (en) * 1952-10-03 1954-09-22 Horlicks Ltd A tablet for use in treating peptic ulcers
GB906422A (en) * 1958-05-02 1962-09-19 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical preparations
US3015611A (en) * 1959-08-25 1962-01-02 Nysco Lab Inc Low density whey-bound tablets
GB1063872A (en) * 1962-08-11 1967-03-30 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical compositions
US3594467A (en) * 1968-10-09 1971-07-20 Richardson Merrell Inc Long-lasting troche
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE3250023T (enExample) * 1981-01-14 1990-03-29
FR2524312B1 (fr) * 1982-04-01 1985-10-04 Tech Cuir Centre Nouvelles formes de micro-encapsulation de substances medicamenteuses par des couches homogenes de collagene natif
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4670251A (en) * 1984-05-30 1987-06-02 Igene Biotechnology, Inc. Microcrystalline tableting excipient derived from whey
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
IL78017A (en) * 1986-03-03 1989-06-30 Yissum Res Dev Co Sustained release tablets of theophylline
DE3702105A1 (de) * 1987-01-24 1988-08-04 Bayer Ag Parenterale loesung
EP0326618A1 (en) * 1987-03-04 1989-08-09 Nippon Hypox Laboratories Incorporated Medicinal composition containing albumin as carrier and process for its preparation
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
ATE90205T1 (de) * 1987-09-08 1993-06-15 Takeda Chemical Industries Ltd Wasserunloesliche cytokine.

Also Published As

Publication number Publication date
HU204997B (en) 1992-03-30
NZ234593A (en) 1993-04-28
CA2022447A1 (fr) 1991-02-08
FI903885A0 (fi) 1990-08-06
HUT55230A (en) 1991-05-28
KR910004181A (ko) 1991-03-28
IL95105A0 (en) 1991-06-10
FR2650502A1 (fr) 1991-02-08
FI903885A7 (fi) 1991-02-08
TNSN90111A1 (fr) 1991-03-05
NO903442L (no) 1991-02-08
DE4023136A1 (de) 1991-02-14
CS276556B6 (en) 1992-06-17
GB2234898A (en) 1991-02-20
FR2650502B1 (fr) 1994-05-27
IE902629A1 (en) 1991-02-27
LU87777A1 (fr) 1990-12-11
HU904909D0 (en) 1991-01-28
JPH0377819A (ja) 1991-04-03
ZA905886B (en) 1991-04-24
CS383890A3 (en) 1992-06-17
IN170789B (enExample) 1992-05-23
NO903442D0 (no) 1990-08-06
PE491A1 (es) 1991-01-26
GB9017144D0 (en) 1990-09-19
MA21923A1 (fr) 1991-04-01
OA09301A (fr) 1992-09-15
AU6023990A (en) 1991-02-07
PT94823A (pt) 1991-04-18
AU631235B2 (en) 1992-11-19
EP0412877A1 (fr) 1991-02-13
DD297332A5 (de) 1992-01-09

Similar Documents

Publication Publication Date Title
CN1025150C (zh) 能延续释放的新药物制剂的制备方法
FI87424C (fi) Foerfarande foer framstaellning av fasta nifedipinpreparat, som biologiskt laett kan tillgodogoeras och som har en foerdroejd effekt
CN1029935C (zh) 制备新药物制剂的方法
KR101483203B1 (ko) 무정형 ｃｄｄｏ-ｍｅ를 포함하는, 지연 방출형 경구 투여 조성물
JP2916152B2 (ja) 薬物放出速度調節型製剤
EP2200588B1 (en) Compositions comprising lipophilic active compounds and method for their preparation
TWI268778B (en) Benzamide derivative-containing pharmaceutical formulation having improved solubility and oral absorptivity
WO1988006457A1 (fr) Composition medicinale contenant de l'albumine en tant que support et procede de preparation
CN107666914A (zh) 帕博西尼的固体剂型
FR2559064A1 (fr) Composition pharmaceutique a biodisponibilite elevee et procede pour la preparer
EA019614B1 (ru) Усовершенствованная фармацевтическая композиция, содержащая антагонист дигидропиридинкальциевого канала, и способ ее получения
CN1499930A (zh) 生物利用度提高的抗真菌组合物
CN1489468A (zh) 甾类激素产品及其制备方法
CN1450891A (zh) 基于肝素、葡糖胺聚糖或类肝素的制剂以及这种制剂和制剂基质的应用
KR20100038188A (ko) 수분산성 건성 약학적 조성물의 신규 제조 방법 및 그에 의해 수득한 약학적 조성물
CN1068739A (zh) 二脱氧嘌呤核苷类药物改进的口服剂型
JP3518601B2 (ja) エバスタイムまたはその類似体に基づく医薬組成物
TWI316406B (en) Novel pharmaceutical formulations of modafinil
CN1946426A (zh) 用于口服施用HMG－CoA还原酶抑制剂的持续释放制剂和其制备方法
JPWO2002069957A1 (ja) フェノフィブラート含有組成物
CN1939358A (zh) 肿节风分散片
JPS61227524A (ja) プラゾシン製剤及びその製法
CN114177142B (zh) 一种普拉沙星肠溶固体分散体与含有该固体分散体的制剂
TWI351399B (en) Pharmaceutical formulations and compositions of a
CN100341495C (zh) 格列本脲固体分散体、口服组合物及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication